Variable penetrance of schizophrenia in 22q11.2 deletion syndrome is associated with impaired, but reversible, neuronal mitophagy.
In the authors' words
The 22q11.2 deletion syndrome (22qDS) is a major genetic risk factor for schizophrenia (Sz). We found that iPSC-derived neurons (iNeurons) from 22qDS +Sz individuals exhibit weaker mitochondrial energetics, whereas iNeurons from individuals with the same deletion but no psychosis (22qDS -Sz) upregulate expression of mitochondrial biogenesis-related genes. Here, we investigated why the +Sz group fails to undergo this compensation, finding that 22qDS +Sz iNeurons have older and more depolarized mitochondria than 22qDS -Sz or controls. Transcriptomic and proteomic analyses revealed downregulation of mitophagy-related pathways, and live imaging revealed elevated lysosomal pH. Restoring lysosomal acidity with acidifying nanoparticles improved mitophagy and, remarkably, increased the expression of mitochondrial biogenesis-related transcription factors in the +Sz neurons. We conclude that lysosomal dysfunction and impaired mitophagy differentiate 22qDS individuals who develop schizophrenia from those who do not. Mitophagy could be a novel therapeutic or preventative opportunity for Sz in the context of genetic neurodevelopmental disorders.
Appeared: Tuesday, November 17. bioRxiv. Preprint, not yet peer-reviewed.